AXONIS Therapeutics is a biotechnology developing therapies for currently incurable neurological disorders. AXONIS Therapeutics is progressing a pipeline of neuron-reviving therapeutics which enable an intrinsic ability of central nervous system (CNS) neurons to resist degeneration; restore excitation/inhibition balance; and regenerate.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/14/21 | $5,000,000 |
Alexandria Venture Investments BoxOne Ventures Christopher & Dana Reeve Foundation Civilization Ventures R3 Bio Spinal Research | undisclosed | |
| 11/04/24 | $115,000,000 | Series A |
Cormorant Asset Management Lumira Ventures MRL Ventures Fund Perceptive Advisors Sofinnova Ventures Solasta Ventures VenBio | undisclosed |
